Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
As proton beam therapy use for cancer increased, ‘so did the racial disparity in receipt’
Use of proton beam therapy increased significantly among patients with cancer in the U.S. between 2004 and 2018, but Black individuals had a lower likelihood of receiving the therapy than their white counterparts.
Phase 3 trial of combination for advanced lung cancer misses co-primary endpoint
A randomized phase 3 trial designed to evaluate tiragolumab plus atezolizumab for certain patients with advanced lung cancer failed to meet its co-primary endpoint of PFS, topline data showed.
Log in or Sign up for Free to view tailored content for your specialty!
Healio/HemOnc Today to honor Disruptive Innovators at ASCO
THOROFARE, NJ — Healio is set to host the inaugural hematology/oncology Disruptive Innovators Award Reception during the American Society of Clinical Oncology Annual Meeting. The event will take place on June 4, 2022, at the Hyatt Regency McCormick Place in Chicago, Illinois.
Radiation technique reduces symptomatic esophagitis in patients with advanced lung cancer
Esophageal-sparing intensity-modulated radiotherapy did not significantly improve esophageal quality of life but reduced incidence of symptomatic esophagitis among patients with advanced non-small cell lung cancer.
Will telehealth face hurdles in access, coverage in a post-pandemic world?
Click here to read the Cover Story, “ Pandemic proves telehealth ‘works in saving lives’ and ‘that we have an inequitable system’ ”
Pandemic proves telehealth ‘works in saving lives’ and ‘that we have an inequitable system’
Over the last decade, “telehealth” became a buzzword in conversations about health care innovation.
AYA cancer survivors at higher risk for death due to second primary cancers
Death due to a second primary cancer occurred nearly twice as often among adolescent and young adult cancer survivors compared with the general population, according to study results published in Journal of the National Cancer Institute.
Early lung cancer detection improves survival rates
Healio spoke with Rebecca L. Siegel, MPH, senior scientific direct of surveillance research at the American Cancer Society, to learn more about earlier detection of lung cancer and how it has helped patients increase their odds of survival and helped clinicians effectively treat their patients.
Incidental respiratory findings on low-dose CT lung cancer screening common
Incidental respiratory disease-related findings, including emphysema and reticular opacities, observed on low-dose CT lung cancer screenings were common and associated with increased mortality, researchers reported.
New CEO of IASLC: ‘It’s important to take new opportunities’
In her new role as CEO of the International Association for the Study of Lung Cancer, or IASLC, Karen Kelly, MD, has seen her reach as a leader expand from local to global.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read